Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-15

Clinical Trial Update: Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of AN2690 topical solution for toenail onychomycosis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AN2690 topical solution (AN2690)

Snippet

Sponsor: Pfizer | Conditions: Onychomycosis of Toenails | Phase 3 | Status: COMPLETED | Results posted: 2014-08-15